Results 111 to 120 of about 6,393 (198)
INTRODUCTION American tegumentary leishmaniasis (ATL) is an endemic disease in many regions of Brazil; however, only few reports on the actual epidemiological conditions are available.
Priscila Wolf Nassif +7 more
doaj +1 more source
En 98 casos de Leishmaniasis cutánea y cutáneo-mucosa, se encontró relaci n importante entre infiltrado plasmocitario y la presencia del parásito; en cuanto el infiltrado linfocitario y/o granulomatoso, aparecia en los casos donde el parásito estaba ...
Esperanza Azogue C.
core +1 more source
Leishmaniasis recidivans in Ethiopia: cutaneous and mucocutaneous features
Cutaneous leishmaniasis (CL) is endemic in Ethiopia. An unusual clinical form of this disease is leishmaniasis recidivans (LR), a prolonged, relapsing form of cutaneous leishmaniasis resembling tuberculosis of the skin that may persist for many years ...
Federica Dassoni +3 more
core +1 more source
Treatment of mucocutaneous leishmaniasis – A systematic review
SummaryMucocutaneous leishmaniasis is a severe infectious disease, predominantly endemic in Central and South America and is characterized by granulomatous, destructive mucosal lesions in the oral, nasal, and pharyngeal cavities. It is caused by protozoa of the genus Leishmania spp. transmitted to humans by sandflies. Mucocutaneous leishmaniasis occurs
Theresa Fischer +3 more
openaire +2 more sources
Epidemiology of cutaneous and mucocutaneous leishmaniasis in Nicaragua. [PDF]
Hernández-Bojorge SE +4 more
europepmc +1 more source
Ear, nose and throat manifestations of mucocutaneous Leishmaniasis: a literature review
Summary. Leishmaniasis comprises a group of diseases caused by a protozoan parasite belonging to the genus Leishmania and transmitted by the bite of infected female sand flies. Leishmaniasis is endemic in 88 countries and causes significant morbidity and
Maria Celeste Chiappetta +2 more
core
A Review of the Progress in the Development of Leishmaniasis Vaccines [PDF]
Leishmaniasis is a parasitic infectious disease that accounts for approximately one million new cases annually. The treatment of this disease is complex and costly, particularly in developing countries.
Narges Khaghanzadeh +2 more
doaj
Visceral Dissemination of Mucocutaneous Leishmaniasis in a Kidney Transplant Recipient. [PDF]
Marques N +18 more
europepmc +1 more source
Mucocutaneous leishmaniasis in a cocaine user: diagnostic and therapeutic knowledge. [PDF]
Sbroglio LL +5 more
europepmc +1 more source

